1. Colin Hopper

    0 Comments Related Articles

    1. Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Colin Hopper

    Colin Hopper

    Colin Hopper, M.D., Head, Unit of Oral and Maxillofacial Surgery, Division of Maxillofacial, Diagnostic, Medical and Surgical Sciences at the University College London Eastman Dental Institute.  Since 1991 Mr Hopper has been working in the National Medical Centre. In this position he has lead a variety of research projects on the use of photodynamic therapy in the treatment of oral squamous cell carcinoma. This program is currently one of the largest in the world with over 400 treatments using the three main photosensitizers. Mr Hopper is the principal investigator on a series of ethically approved projects. His work has resulted in a number of publications and helped establish a clear role for this treatment in a variety of neoplastic conditions in the head and neck. This work has advanced rapidly by the development of interstitial treatment of tumours using image guidance systems developed with the department of imaging and medical physics. This has become a national referral service and approval of PDT for treat of cancer has been recognised as such in 2002. Other related areas of research are fluorescence diagnostics (optical techniques for tissue interrogation) and the use of PDT in the treatment of non-malignant conditions such as neurofibromatosis.

  3. Quotes

    1. This case study is part of a larger programme of ground-breaking research at our unit into using OCT imaging for clinical benefit of cancer patients...As well as improving PDT, mapping skin cancer lesions with OCT should improve delivery of other treatments. We are looking to integrate OCT into our routine clinical pathway.
      In OCT mapping tracks skin cancer during PDT
    2. These ex-vivo results are very encouraging and we expect the in-vivo results to be even better, due to better contrast on perfused tissue.
      In Michelson Diagnostics Reports First Quantitative Results on Cancer Diagnosis Using Multi-beam OCT imaging
    3. If we can catch it early, the incipient tumour is small and can be easily excised, for a complete cure in most cases. but if it has been allowed to develop, the treatment is expensive, invasive, often disfiguring surgery, with a poor prognosis. We really need a fast, non-invasive way to scan the many lumps that develop in the mouths of users of tobacco, alcohol and betel nut, to see when one is developing a cancer – now, it really looks like OCT imaging is the answer
      In Michelson Diagnostics Reports First Quantitative Results on Cancer Diagnosis Using Multi-beam OCT imaging
    4. We are very excited about the breakthrough in image quality that this system offers.
      In Successful OCT Imaging Of Oral Cancer Tissue Announced By MDL And UCH, UK
    5. We are very excited about the breakthrough in image quality that this system offers.
      In OCT market set for rapid growth